Integra Lifesciences Holdings (IART) Capital Expenditures Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Integra Lifesciences Holdings | 1.20 Bn | 939.16 Mn | 216.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.34% |
| Dec 31, 2025 | 15.36% |
| Sep 30, 2025 | 17.64% |
| Jun 30, 2025 | 22.79% |
| Mar 31, 2025 | 11.85% |
| Dec 31, 2024 | 5.93% |
| Sep 30, 2024 | 16.88% |
| Jun 30, 2024 | 10.96% |
| Mar 31, 2024 | -0.78% |
| Dec 31, 2023 | -0.91% |
| Sep 30, 2023 | -4.74% |
| Jun 30, 2023 | -4.91% |
| Mar 31, 2023 | -2.29% |
| Dec 31, 2022 | 1.08% |
| Sep 30, 2022 | 3.27% |
| Jun 30, 2022 | -6.00% |
| Mar 31, 2022 | 0.29% |
| Dec 31, 2021 | 5.29% |
| Sep 30, 2021 | 0.88% |
| Jun 30, 2021 | -4.31% |
| Mar 31, 2021 | -9.33% |
| Dec 31, 2020 | -8.44% |
| Sep 30, 2020 | 4.64% |
| Jun 30, 2020 | -5.59% |
| Mar 31, 2020 | 25.39% |
| Dec 31, 2019 | 14.59% |
| Sep 30, 2019 | 16.20% |
| Jun 30, 2019 | 13.55% |
| Mar 31, 2019 | 7.25% |
| Dec 31, 2018 | 41.18% |
| Sep 30, 2018 | 4.70% |
| Jun 30, 2018 | 7.98% |
| Mar 31, 2018 | 7.23% |
| Dec 31, 2017 | -11.10% |
| Sep 30, 2017 | -16.94% |
| Jun 30, 2017 | -2.07% |
| Mar 31, 2017 | -2.46% |
| Dec 31, 2016 | 10.19% |
| Sep 30, 2016 | -10.65% |
| Jun 30, 2016 | 2.76% |
| Mar 31, 2016 | 12.97% |
| Dec 31, 2015 | -6.41% |
| Sep 30, 2015 | -5.74% |
| Jun 30, 2015 | -11.41% |
| Mar 31, 2015 | 23.70% |
| Dec 31, 2014 | -0.10% |
| Sep 30, 2014 | 2.46% |